What does this TikTok creator actually claim?
Daniela Segura posted about losing 12 kilos (26 pounds) over three months using weekly semaglutide injections at MagicalMedSpa. She credits the GLP-1 medication with improving her energy levels and overall health beyond just weight loss.
The creator positions this as a supervised medical treatment rather than a quick fix. She's documenting ongoing weekly sessions and framing semaglutide as a "life-changing treatment."
While she doesn't specify her starting weight or dose, losing 26 pounds in 12 weeks works out to about 2.2 pounds per week. That's aggressive but potentially realistic for semaglutide users.
Does the science support these weight loss claims?
The numbers aren't outrageous for semaglutide. The STEP 1 trial (Wilding et al., NEJM, 2021) found 14.9% average body weight reduction at 68 weeks with 2.4mg weekly doses. That study involved 1,961 adults without diabetes.
But here's the thing: most of semaglutide's dramatic weight loss happens after month three, not during it. The STEP trials showed average losses of 6-8% in the first 12 weeks.
If Daniela started at 140 pounds, losing 26 pounds represents an 18.6% reduction. That would put her in the top 10% of responders, which is possible but uncommon in early treatment.
What's missing from this success story?
The creator doesn't mention side effects, which hit about 74% of people in clinical trials. Nausea affects roughly 44% of users at the 2.4mg dose, according to the STEP 1 data.
She also skips the lifestyle component entirely. The STEP trials included reduced-calorie diets and 150 minutes of weekly exercise. Semaglutide alone, without dietary changes, produces much smaller weight losses.
Most concerning: she's getting treatment at a med spa, not from an endocrinologist or primary care doctor. While legal, this setup often lacks the comprehensive monitoring that GLP-1 medications require.
Are the energy claims legitimate?
This part gets tricky because energy improvements aren't directly measured in semaglutide trials. The STEP studies focused on weight, not subjective wellness measures.
However, the STEP 1 trial did show improvements in physical functioning scores on the SF-36 questionnaire. People reported better mobility and less physical limitation.
Weight loss itself often improves energy levels, so Daniela's experience could be real. But attributing it specifically to semaglutide rather than being 26 pounds lighter is misleading.
What should you actually know about semaglutide?
Semaglutide works by mimicking GLP-1, a hormone that slows stomach emptying and reduces appetite. The 2.4mg dose (Wegovy) is specifically approved for weight management, while lower doses (Ozempic) target diabetes.
The medication costs $1,300-1,500 monthly without insurance. Most people regain weight when they stop, according to the STEP 1 extension study.
Real medical supervision matters more than Daniela suggests. You need monitoring for pancreatitis, gallbladder problems, and potential thyroid issues. A legitimate provider will also address diet and exercise, not just hand you injections.